Home » ASPREVA SEES 1Q REVENUE OF $62 MILLION
ASPREVA SEES 1Q REVENUE OF $62 MILLION
Pharmaceutical company Aspreva Pharmaceuticals
Corp. said Thursday it expects to report first-quarter revenue of about $62 million,
aided by a higher-than-expected payment under its collaboration agreement with
Roche Holding Ltd.
Business
Week
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May